1. Ahn SJ, Ryoo NK, Woo SJ. Ocular toxocariasis: clinical features, diagnosis, treatment, and prevention. Asia Pac Allergy. 2014; 4:134–141.
2. Stewart JM, Cubillan LD, Cunningham ET Jr. Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina. 2005; 25:1005–1013.
3. Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003; 16:265–272.
4. Despreaux R, Fardeau C, Touhami S, et al. Ocular toxocariasis: clinical features and long-term visual outcomes in adult patients. Am J Ophthalmol. 2016; 166:162–168.
5. Ahn SJ, Woo SJ, Jin Y, et al. Clinical features and course of ocular toxocariasis in adults. PLoS Negl Trop Dis. 2014; 8:e2938.
6. Nicholson BP, Nigam D, Miller D, et al. Comparison of wide-field fluorescein angiography and 9-field montage angiography in uveitis. Am J Ophthalmol. 2014; 157:673–677.
7. Kaines A, Tsui I, Sarraf D, Schwartz S. The use of ultra wide field fluorescein angiography in evaluation and management of uveitis. Semin Ophthalmol. 2009; 24:19–24.
8. Soliman AZ, Silva PS, Aiello LP, Sun JK. Ultra-wide field retinal imaging in detection, classification, and management of diabetic retinopathy. Semin Ophthalmol. 2012; 27:221–227.
9. Prasad PS, Oliver SC, Coffee RE, et al. Ultra wide-field angiographic characteristics of branch retinal and hemicentral retinal vein occlusion. Ophthalmology. 2010; 117:780–784.
10. Anderson L, Friberg TR, Singh J. Ultrawide-angle retinal imaging and retinal detachment. Semin Ophthalmol. 2007; 22:43–47.
11. Lee HW, Kim HC. A case of atypical acute retinal necrosis observed using ultra-wide-field imaging. J Korean Ophthalmol Soc. 2015; 56:452–457.
12. Bae KW, Ahn SJ, Park KH, Woo SJ. Diagnostic value of the serum anti-toxocara IgG titer for ocular toxocariasis in patients with uveitis at a tertiary hospital in Korea. Korean J Ophthalmol. 2016; 30:258–264.
13. Jin Y, Shen C, Huh S, et al. Serodiagnosis of toxocariasis by ELISA using crude antigen of toxocara canis larvae. Korean J Parasitol. 2013; 51:433–439.
14. Kim YH, Huh S, Chung YB. Seroprevalence of toxocariasis amomg healthy people with eosinophilia. Korean J Parasitol. 2008; 46:29–32.
15. Kwon NH, Oh MJ, Lee SP, et al. The clinical impact of toxocariasis in patients with unknown eosinophilia. Korean J Asthma Allergy Clin Immunol. 2005; 25:299–304.
16. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data Results of the First International Workshop. Am J Ophthalmol. 2005; 140:509–516.
17. Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985; 92:467–471.
18. Sugar EA, Jabs DA, Altaweel MM, et al. Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography. Am J Ophthalmol. 2011; 152:1044–1052.e5.
19. Stevenson W, Prospero Ponce CM, Agarwal DR, et al. Epiretinal membrane: optical coherence tomography-based diagnosis and classification. Clin Ophthalmol. 2016; 10:527–534.
20. Kang HM, Lee SC. Long-term progression of retinal vasculitis in Behçet patients using a fluorescein angiography scoring system. Graefes Arch Clin Exp Ophthalmol. 2014; 252:1001–1008.
21. Kim M, Kwon HJ, Choi EY, et al. Correlation between fluorescein angiographic findings and visual acuity in Behçet retinal vasculitis. Yonsei Med J. 2015; 56:1087–1096.